Early Combination Therapy of Ketamine and Midazolam in Patients with Refractory Status Epilepticus in Hemodynamic Unstable State
Jung-Won Choi, Jung-Won Shin
J Epilepsy Res. 2021;11(2):150-153.   Published online 2021 Dec 31     DOI: https://doi.org/10.14581/jer.21023
Citations to this article as recorded by Crossref logo
Ketamine: Pro or antiepileptic agent? A systematic review
Islam Mohammad Shehata, Neveen A. Kohaf, Mohamed W. ElSayed, Kaveh Latifi, Aya Moustafa Aboutaleb, Alan David Kaye
Heliyon.2024; 10(2): e24433.     CrossRef
Ketamine in the treatment of refractory and super-refractory status epilepticus: Experience from two centres
Manuel García-Ruiz, Pablo Mayo Rodríguez, Luca Palliotti, Clara Lastras, María Romeral-Jiménez, Irene García Morales, Cándido Pardo Rey, Marc Rodrigo-Gisbert, Daniel Campos-Fernández, Estevo Santamarina, Beatriz Parejo Carbonell
Seizure: European Journal of Epilepsy.2024; 117: 13.     CrossRef
Safety and Efficacy of Ketamine Without Intubation in the Management of Refractory Seizures: A Case Series
Lauren A. Kimmons, Mohammad Alzayadneh, E. Jeffrey Metter, Khalid Alsherbini
Neurocritical Care.2023;[Epub]     CrossRef
Ketamine Efficacy for Management of Status Epilepticus: Considerations for Prehospital Clinicians
Nikhil C. Williams, Lindsey A. Morgan, Jonathan Friedman, Jeffrey Siegler
Air Medical Journal.2023;[Epub]     CrossRef
Management strategies for refractory status epilepticus
Jung-Won Shin
Journal of Neurocritical Care.2023; 16(2): 59.     CrossRef
Development of a Novel and Stable Indicating RP-HPLC Method for the Simultaneous Analysis of 12 Impurities in Midazolam and Midazolam Injection Products
Dandan Chen, Dandan Shen, Li Huang, Lixin Hou, Youming Xiong, Linggao Zeng, Jianhua Wang
Chromatographia.2022; 85(10-11): 949.     CrossRef